Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Block Listing Six Monthly Return
Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, makes the following six-monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies:
Name of applicant:
Induction Healthcare Group PLC
LEI: 213800RY96GCZQW5TP19
Name of scheme:
The Induction Healthcare NTA Share Option Plan
Period of return:
From: 27/07/2022 To:26/01/2023
Number and class of securities originally admitted and the date of admission
3,500,000 ordinary shares on 26 July 2021
Balance of unallotted securities under scheme(s) from initial application:
3,103,433
Plus: The amount by which the block scheme(s) has been increased since the date of
the last return (if any increase has been applied for):
Nil
Less: Number of securities issued/allotted under scheme(s) during the period:
Nil
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
3,103,433
Contact:
Louise Torr, Company Secretary
louise.t@inductionhealthcare.com
ENQUIRIES Induction
Christopher Samler, Executive Chair
Paul Tambeau, Chief Operating Officer
Via Walbrook PR Ltd: induction@walbrookpr.com
Singer Capital Markets (Nominated Adviser and Broker)
+44 (0)20 7496 3000
Philip Davies
Walbrook PR Ltd
induction@walbrookpr.com
Paul McManus / Alice Woodings
Mob: +44(0)7980 541 893 / +44 (0)7407 804 654
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
